Expression of bcl-2 in rheumatoid arthritis

British Journal of Rheumatology

Volumn 35, Issue 7, 1996, Pages 611-619

  Isomaki P ^a,e   Soderstrom K O ^b   Punnonen, J ^a   Roivainen, A ^a   Luukkainen, R ^d   Merilahti Palo, R ^b,c   Nikkari, S ^a   Lassila, O ^a   Toivanen, P ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b Turku University   (Finland)

^c Turunmaan Sairaala   (Finland)

^d Satalinnan Sairaala   (Finland)

^e TURKU UNIVERSITY   (Finland)

Author keywords

bcl 2; Lymphocytes; Rheumatoid arthritis

Indexed keywords

ANTIRHEUMATIC AGENT; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN BCL 2; STEROID;

ADULT; AGED; APOPTOSIS; ARTICLE; AUTOIMMUNITY; BLOOD; CONTROLLED STUDY; ETIOLOGY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NUCLEIC ACID HYBRIDIZATION; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; REACTIVE ARTHRITIS; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIUM; T LYMPHOCYTE;

EID: 0029885338     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/35.7.611     Document Type: Article

References (54)

1. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988;335:440-2.
2. Nunez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ. Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 1990;144:3602-10.
3. Fanidi A, Harrington EA, Evan GI. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 1992;359:554-6.
4. Garcia I, Martinou I, Tsujimoto Y, Martinou J-C. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science 1992;258: 302-4.
5. Tsujimoto Y, Gorham J, Cossman J, Jaffe E, Croce CM. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 1985;229:1390-3.
6. Bakhski A, Jensen JP, Goldman P et al. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 1985;41:889-906.
7. Cleary ML, Sklar J. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 1985;82:7439-43.
8. Pezzella F, Tse AGD, Cordell JL, Pulford KAF, Gatter KC, Mason DY. Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol 1990;137:225-32.
9. Veis DJ, Sentman CL, Bach EA, Korsmeyer SJ. Expression of the bcl-2 protein in murine and human thymocytes and in peripheral T lymphocytes. J Immunol 1993;151:2546-54.
10. Hockenbery D, Zutter M, Hickey W, Nahm M, Korsmeyer SJ. Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991;88:6961-5.
11. Merino R, Ding L, Veis DJ, Korsmeyer SJ, Nunez G. Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO J 1994;13:683-91.
12. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ. Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 1991; 67:879-88.
13. Nakayama K, Nakayama K, Negishi I et al. Disappearance of the lymphoid system in bcl-2 homozygous mutant chimeric mice. Science 1993;261:1584-8.
14. Nunez G, Hockenbery D, McDonnell TJ, Sorensen CM, Korsmeyer SJ. Bcl-2 maintains B cell memory. Nature 1991;353:71-3.
15. Strasser A, Whittingham S, Vaux DL et al. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci USA 1991;88:8661-5.
16. Strasser A, Harris AW, Cory S. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 1991;67:889-99.
17. Hartley SB, Cooke MP, Fulcher DA et al. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell 1993;72: 325-35.
18. Nisitani S, Tsubata T, Murakami M, Okamoto M, Honjo T. The bcl-2 gene product inhibits clonal deletion of self-reactive B lymphocytes in the periphery but not in the bone marrow. J Exp Med 1993;178: 1247-54.
19. Garchon H-J, Luan J-J, Eloy L, Bedossa P, Bach J-F. Genetic analysis of immune dysfunction in non-obese diabetic (NOD) mice: mapping of a susceptibility locus close to the bcl-2 gene correlates with increased resistance of NOD T cells to apoptosis induction. Eur J Immunol 1994;24:380-4.
20. Watanabe-Fukunaga R, Brannan CI, Copeland N, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992;356:314-7.
21. Hang L, Theophilopoulos AN, Dixon FJ. A spontaneous rheumatoid arthritis-like disease in MRL/I mice. J Exp Med 1982;155:1690.
22. Gatenby PA, Irvine M. The bcl-2 proto-oncogene is overexpressed in systemic lupus erythematosus. J Autoimmun 1994;7:623-31.
23. Oshako S, Hara M, Harigai M, Fukasawa C, Kashiwazaki S. Expression and function of fas antigen and bcl-2 in human systemic lupus erythematosus lymphocytes. Clin Immunol Immunopathol 1994;73: 109-14.
24. Aringer M, Wintersberger W, Steiner CW et al. High levels of bcl-2 protein in circulating T lymphocytes but not B lymphocytes of patients with systemic lupus erythematosus. Arthritis Rheum 1994;37:1423-30.
25. Cush JJ, Lipsky PE. Phenotypical analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis. Arthritis Rheum 1988;31:1230-7.
26. Afeltra A, Galeazzi M, Ferri GM et al. Expression of CD69 antigen on synovial fluid T cells in patients with rheumatoid arthritis and other chronic synovitis. Ann Rheum Dis 1993;52:457-60.
27. Hemler ME, Glass D, Coblyn JS, Jacobson JG. Very late activation antigens on rheumatoid synovial fluid T lymphocytes. J Clin Invest 1986;78:696-704.
28. Eliaou JF, Andary M, Favier F et al. Increase of class II HLA molecules on the membrane of B lymphocytes from patients with rheumatoid arthritis. Autoimmunity 1988;1:217.
29. Wernick RM, Lipsky PE, Marban-Arcos E, Maliakkal JJ, Edelbaum D, Ziff M. IgG and IgM rheumatoid factor synthesis in rheumatoid synovial membrane cell cultures. Arthritis Rheum 1985;28:742-52.
30. Mountz JD, Wu J, Cheng J, Zhou T. Autoimmune disease: a problem of defective apoptosis. Arthritis Rheum 1994;37:1415-20.
31. Arnett FC, Edworthy SM, Bloch DA. et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
32. Toivanen A. Reactive arthritis. In: Klippel J, Dieppe P, eds. Rheumatology. St Louis, MO: Mosby-Year Book Europe Limited, 1994.
33. Altman R. Classification of disease: Osteoarthritis. Semin Arthritis Rheum 1991;20(suppl. 2):40-7.
34. Veromaa T, Vainio O, Eerola E, Toivanen P. Monoclonal antibodies against chicken Bu-1a and Bu-1b alloantigens. Hybridoma 1988;7:41-8.
35. de Waal Malefyt R, Abrams J, Bennett B, Fidgor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174: 1209-20.
36. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18:5294-9.
37. Nunez G, Seto M, Seremetis S et al. Growth- and tumor-promoting effects of deregulated BCL2 in human B-lymphoblastoid cells. Proc Natl Acad Sci USA 1989;86:4589-93.
38. Dani C, Piechaczyk M, Audigier Y et al. Characterization of the transcription products of glyceraldehyde 3-phosphate-dehydrogenase gene in HeLa cells. Eur J Biochem 1984;145:299-304.
39. Akbar AN, Borthwick N, Salmon M et al. The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J Exp Med 1993;178:427-38.
40. Aiello A, Delia D, Borrello MG et al. Flow cytometric detection of the mitochondrial bcl-2 protein in normal and neoplastic human lymphoid cells. Cytometry 1992; 13:502-9.
41. Deng G, Podack ER. Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2. Proc Natl Acad Sci USA 1993;90: 2189-93.
42. Chen E, Keystone EC, Fish EN. Restricted cytokine expression in rheumatoid arthritis. Arthritis Rheum 1993; 36:901-10.
43. Fluckiger A-C, Durand I, Banchereau J. Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells. J Exp Med 1994;179:91-9.
44. Isomäki P, Luukkainen R, Saario R, Toivanen P, Punnonen J. Interleukin-10 functions as an anti-inflammatory cytokine in rheumatoid synovium. Arthritis Rheum 1996;39:386-95.
45. Llorente L, Richaud-Patin Y, Fior R et al. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. Arthritis Rheum 1994;37:1647-55.
46. Cheng J, Zhou T, Liu C et al. Protection from fas-mediated apoptosis by a soluble form of the fas molecule. Science 1994;263:1759-62.
47. Reed JC, Tsujimoto Y, Alpers JD, Croce CM, Nowell PC. Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation. Science 1987;236:1295-9.
48. Graninger WB, Seto M, Boutain B, Goldman P, Korsmeyer SJ. Expression of bcl-2 and bcl-2-Ig fusion transcripts in normal and neoplastic cells. J Clin Invest 1987;80:1512-5.
49. Thomas R, McIlraith M, Davis LS, Lipsky PE. Rheumatoid synovium is enriched in CD45RBdim mature memory T cells that are potent helpers for B cell differentiation. Arthritis Rheum 1992;35:1455-65.
50. Radvanyi LG, Mills GB, Miller RG. Religation of the T cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptotic cell death. J Immunol 1993;150:5704-15.
51. Wesselborg S, Janssen O, Kabelitz D. Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J Immunol 1993;150: 4338-45.
52. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell 1993;74: 609-19.
53. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ. Bad, a heterodimeric partner for bcl-xL and bcl-2, displaces bax and promotes cell death. Cell 1995;80:285-91.
54. Boise LH, Gonzales-Garcia M, Postema CE et al. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993;74:597-608.